Detail akcie Galenica Sante Rg online

Business Summary: Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Galenica AG revenues increased 5% to SF2B. Net income applicable to common stockholders excluding extraordinary items increased 12% to SF88.3M. Revenues reflect Products & Care segment increase of 99% to SF1.54B, Retail Sales-Local Pharmacies increase of 5% to SF693.1M. Net income benefited from Financial Income - Balancing value increase from SF1.5M to SF4.9M (income).